Purpose: There is much controversy regarding the use of oral contraceptive pills (OCPs) on cardiometabolic parameters, which is why this longitudinal population-based study was conducted to assess the impact of OCP use and its duration on cardiometabolic factors. Methods: Of 5532 reproductive-aged participants of the Tehran lipid and glucose study, 3160 women who met our inclusion criteria were subdivided according to the duration of OCPs consumption into four sub-groups: (1) Non-users; (2) <11 month users; (3) 12-35 month users, and (4) ≥36 month users, and their cardiometabolic parameters were compared. Results: No statistical significant differences were observed between the cardiometabolic parameters of these sub-groups, after further adjustment for confounding factors including age, parity, and education, except for mean low-density lipoprotein-cholesterol which was significantly higher in women who used OCPs for >36 months in comparison to non-OCP users. The odds ratio of hypercholesterolemia was significantly higher in women who used OCPs for >36 months in comparison to non-OCP users; being 1.5 times higher than non-users (95 % CI 1.01-2.2). Conclusion: Results showed that if used for less than 3 years, OCPs have no cardiometabolic effects.
CITATION STYLE
Farahmand, M., Ramezani Tehrani, F., Rostami Dovom, M., Hashemi, S., & Azizi, F. (2016). The impact of oral contraceptives on cardiometabolic parameters. Journal of Endocrinological Investigation, 39(3), 277–283. https://doi.org/10.1007/s40618-015-0346-z
Mendeley helps you to discover research relevant for your work.